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Alzheimer’s disease (AD) is the most common form of dementia and is distinguished
from other dementias by observation of extracellular Amyloid-b (Ab) plaques and
intracellular neurofibrillary tangles, comprised of fibrils of Ab and tau protein, respectively.
At early stages, AD is characterized by minimal neurodegeneration, oxidative stress,
nucleolar stress, and altered protein synthesis machinery. It is generally believed that
Ab oligomers are the neurotoxic species and their levels in the AD brain correlate with
the severity of dementia suggesting that they play a critical role in the pathogenesis of
the disease. Here, we show that the incubation of differentiated human neuroblastoma
cells (SHSY5Y) with freshly prepared Ab42 oligomers initially resulted in oxidative
stress and subtle nucleolar stress in the absence of DNA damage or cell death. The
presence of exogenous Ab oligomers resulted in altered nuclear tau levels as well as
phosphorylation state, leading to altered distribution of nucleolar tau associated with
nucleolar stress. These markers of cellular dysfunction worsen over time alongside a
reduction in ribosomal RNA synthesis and processing, a decrease in global level of
newly synthesized RNA and reduced protein synthesis. The interplay between Ab and
tau in AD remains intriguing and Ab toxicity has been linked to tau phosphorylation and
changes in localization. These findings provide evidence for the involvement of Ab42
effects on nucleolar tau and protein synthesis machinery dysfunction in cultured cells.
Protein synthesis dysfunction is observed in mild cognitive impairment and early AD in
the absence of significant neuronal death.
Keywords: Ab42, oxidative stress, rDNA transcription, rRNA processing, RNA synthesis, protein synthesis,
Alzheimer’s disease, Tau
INTRODUCTION
Alzheimer’s disease (AD) is associated with memory impairment and is characterized by the
deposition of extracellular amyloid plaques and intracellular neurofibrillary tangles. Amyloid-b
(Ab42), the main constituent of the plaques, is believed to be the most toxic species that drives
the pathogenesis of AD according to the original amyloid cascade hypothesis (Hardy and Higgins,
1992). This is supported by biomarker studies, which show that changes in Ab appear decades
before the onset of dementia (Jack et al., 2013). The reformulated amyloid cascade hypothesis
focuses on soluble, oligomeric Ab species as the mediators of neuronal toxicity that may be
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associated with downstream e ects on tau (Selkoe and Hardy,
2016). Levels of Ab oligomers have been shown to correlate
with the disease severity (DaRocha-Souto et al., 2011), while
distribution of tau neurofibrillary tangles correlates with disease
progression (Braak and Braak, 1991). Ab42 oligomers have been
found to cause synaptic aberration (Lacor et al., 2007), disrupt
long-term potentiation (LTP) (Lambert et al., 1998), and cause
memory dysfunction (Zhang et al., 2014), indicating that the
Ab42 oligomers cause a gradual disturbance in cell function
before neuronal loss. Whether Ab changes impact on tau remains
unclear.
Protein synthesis is known to be necessary for formation and
stability of long-term memory. The synthesis of new proteins
is a regulated process that is coordinated from the nucleolus
to the ribosomes. This begins with the formation of functional
ribosomes, which consist of 18S and 28S ribosomal RNA (rRNA),
derived from 45S-pre-ribosomal RNA (45S-pre-rRNA). Several
studies have identified nucleolar stress, ribosome dysfunction,
and alteration of protein synthesis machinery as neurochemical
changes that accompany early AD (Ding et al., 2005; Hernandez-
Ortega et al., 2015). Ribosomal dysfunction, decreased levels
of rRNA and tRNA, and reduced protein synthesis, have been
observed in the brains of patients withmild cognitive impairment
(MCI), indicating that these changes precede neuronal loss that
occurs during AD (Ding et al., 2005). A decrease in many
nucleolar proteins and their mRNA have also been reported in
early AD (Hernandez-Ortega et al., 2015), a period associated
with less neuronal loss (Braak and Braak, 1991). This seems to
suggest that the protein synthesis machinery becomes altered
before the onset of AD and this progresses with the disease
process. Interestingly, tau has been shown to play a role in the
nucleus and nucleolus as well as being a microtubule binding
protein in the cytosol (Maina et al., 2018).
We have previously shown that Ab42 oligomers enter
undi erentiated neuroblastoma (SHSY5Y) cells leading to
lysosomal damage (Soura et al., 2012). In primary hippocampal
neurons, we showed that Ab42, but not a non-toxic variant,
becomes internalized and alters synaptic vesicle recycling
properties (Marshall et al., 2016), establishing a critical role
for Ab42 in driving the neurochemical changes in AD. Here,
we investigated the hypothesis that Ab42 could impact on
localization and function of tau and may be important in the
impairment of the protein synthesis machinery observed in early
AD. We reveal that incubation of di erentiated SHSY5Y cells
with Ab42 oligomers leads to increased oxidative stress and a
gradual accumulation of nucleolar stress. These changes result
in altered production and processing of 45S-pre-ribosomal rRNA
(45S-pre-rRNA), heterochromatin compaction and a decrease in
RNA and protein synthesis, without DNA damage or loss of
cell viability. Furthermore, Ab42 oligomer administration results
in changes in localization and altered phosphorylation state
of nuclear human tau protein in di erentiated SHSY5Y cells.
Changes in levels of nuclear phosphor-tau have been observed
with AD progression (Hernandez-Ortega et al., 2015). This is the
first observation of a central involvement of Ab42 in nucleolar
dysfunction and altered protein synthesis machinery in a cellular
model, which recapitulates the scenario that occurs from MCI
to AD (Ding et al., 2005; Hernandez-Ortega et al., 2015). This
demonstrates that the early changes in Ab42 levels that occur
decades before full-blown AD (Jack et al., 2013) may influence
nuclear tau, and contribute to the altered protein synthesis
machinery, from the nucleolus to the ribosome, which occurs at
the early stage of the disease.
MATERIALS AND METHODS
Cell Culture
Undi erentiated SHSY5Y neuroblastoma cells (Sigma-
Aldrich and originally supplied by Public Health England
culture collections) were maintained in Dulbecco’s Modified
Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12)
(Life Technologies, United Kingdom), supplemented
with 1% (v/v) L-glutamate (L-Gln) (Invitrogen), 1% (v/v)
penicillin/streptomycin (Pen/Strep) (Invitrogen) and 10% (v/v)
Fetal Calf Serum (FCS) at 37 C and 5% CO2. SHSY5Y cells were
di erentiated in a medium containing 1% FCS supplemented
with 10 µM trans-Retinoic acid (Abcam) for 5 days. On day five,
the medium was replaced with a serum-free media supplemented
with 2 nM brain-derived neurotrophic factor (BDNF) (Merck
Millipore). Cells were used 2 days post-BDNF incubation.
Preparation of Ab
Ab42 (rPEPTIDE) was prepared following an established
procedure (Soura et al., 2012). Briefly, the peptide was solubilized
in 1,1,1,3,3,3-hexafluoro-2-propanol (99% purity) (Fluka, Sigma-
Aldrich) and sonicated. The HFIP was removed and dried
Ab was dissolved in Dimethyl sulfoxide (DMSO) >99.9%
(ACROS Organics) at 0.2 mg/ml. Solvents were removed using
a 5 ml HiTrap desalting column (GE Healthcare) in 30 µL
of Hepes bu er [10 mM Hepes, 50 mM NaCl, 1.6 mM
KCl, 2 mM MgCl2·6H2O, 3.5 mM CaCl2·2H2O (pH 7.4)].
Ab peptide concentration was determined using a Nanodrop
spectrophotometer (Thermo Fisher Scientific) at a wavelength of
280 nm (extinction coe cient of 1490). An equivalent of 10 µM
from the Ab42 stock was administered to the medium of the
di erentiated SH-SY5Y cells.
Western Blotting
SHSY5Y cells were fractionated for 15 min on ice using RIPA
(Abcam), supplemented with protease (Sigma) and phosphatase
(Sigma) inhibitors and spun at 16000 ⇥ g for 15 at 4 C. Protein
concentration was quantified using Pierce BCA Protein Assay
Kit (Thermo Fisher Scientific) and absorbance (562 nm) was
read using GloMax Multi-Detection plate reader (Promega).
A total of 10 µg of protein from each sample was diluted in
4⇥ Laemmli sample bu er, supplemented with 1:10 dilution
of b-mercaptoethanol, then loaded to 7.5% Mini-PROTEAN
TGX Stain-Free Protein Gels (BIO-RAD) and SDS-PAGE was
run at 100V using 1⇥ running bu er (25 mM Tris, 192 mM
glycine, 0.1% SDS). The proteins were transferred to PVDF
membrane (Merck Millipore) using 1⇥ transfer bu er [25 mM
Tris–HCl, 192 mM glycine, and 10% (v/v) methanol] at 100 V.
The membrane was blocked in 5% (w/v) milk dissolved in
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washing bu er (TBS-Tween) (MerckMillipore), incubated at 4 C
overnight with primary antibodies diluted in the blocking bu er
(see Supplementary Table 1 for antibodies). The membranes were
washed 5⇥ for 10 min and probed for 1 h with corresponding
secondary antibodies diluted in blocking bu er. The membranes
were washed 5⇥ for 10 min each and subsequently developed
in the dark room after incubation in Clarity Western ECL
substrate for 1 min (BIO-RAD). To ensure the specificity of
the secondary antibodies, control experiments were run using
secondary antibodies, without primary antibodies, and this did
not show any specific chemiluminescent signal. For loading
control antibodies or sequential analyses of other proteins on
the same membrane using other antibodies, the membranes were
stripped using RestoreTM PLUS Western Blot Stripping Bu er
(Thermo Fisher Scientific), then blocked, and probed as described
above. The blots were scanned at high resolution, and then bands
were quantified using ImageJ software.
Immunofluorescence Labeling
SHSY5Y cells were resuspended in PBS and spun onto a glass
slide at 800 RPM for 3 min using Cytospin Centrifuge (CellSpin
I, Tharmac). Cells were fixed with 4% paraformaldehyde/PBS
for 15 min, PBS-washed, permeabilized using 0.5% Triton X-
100/PBS for 15 min and PBS-washed. The slides were blocked
in blocking bu er [4% BSA/PBS/Tween-20 (0.02%)] for 45 min,
incubated with primary antibody diluted in the blocking bu er
for 45 min, PBS-washed, incubated in Alexa fluorophore-
conjugated corresponding secondary antibody diluted in the
blocking bu er for 45 min. The slides were PBS-washed,
incubated in 1/1000 DRAQ5 (Abcam) diluted in PBS/Tween-20
(0.02%) for 10 min and mounted with coverslips using ProLong R 
Gold Antifade mountant (Life Technologies). 5-Methylcytosine
(5-mC), cells on the glass slides were fixed with 2.5% PFA/PBS
for 30 min at RT, PBS-washed, permeabilized for 1 h at RT with
0.5% Triton X-100/PBS. The cells were then washed in wash
bu er [PBS/0.1% Triton X-100 (PBST)] and incubated with 2N
HCl for 30 min at 37 C to depurinate the DNA, followed by
2⇥ 5 min wash with 0.1 M borate bu er (pH 8.5). They were
then rinsed twice with PBS-T, blocked in blocking bu er (1%
BSA/PBS-T) for 1 h at RT, incubated with the primary antibody
diluted in the blocking bu er for 2 h at RT andwashed three times
with PBS-T. Then they were incubated with the corresponding
secondary antibody diluted in the blocking bu er for 45 min at
RT in the dark and washed three times in PBS-T, then stained
with DRAQ5.
Confocal Microscopy Imaging and
Analysis
Images were taken using a 100⇥ oil objective of LSM510 Meta
confocal microscope mounted on Axiovert200M using pinhole
size of 1 Airy unit. All images were collected as Z-stacks for
all channels using a step size of 1 µm to allow the analysis
of the entire signal in the cells. Subsequently, images were
Z-projected to sum all signals and then analyzed using ImageJ.
Five randomly collected images from each experiment and an
average of 50–70 cells per experiment were subjected to the
ImageJ analysis. For the quantification of nuclear foci/cluster,
ImageJ Procedure presented by the light microscopy core facility
of Duke University was used. For the quantification of total
nuclear fluorescence intensities, the nuclei were first segmented
by thresholding using the DRAQ5 channel, excluding fused
nuclei or those at the edges. Subsequently, the multi-measure
option on the ImageJ ROI manager was used to measure nuclear
fluorescence from all channels in only segmented nuclei. The
total corrected nuclear fluorescence (TCNF) was then calculated
as TCNF = Integrated Density – (Area of selected cell ⇥ Mean
fluorescence of background readings) (McCloy et al., 2014). For
the quantification of nucleolar nP-Tau, a similar approach was
used, in which the nucleolus was first segmented by thresholding
using the fibrillarin channel. For the quantification of nucleolar
nP-Tau and FBL redistribution, Z-stack images were Z-projected
to maximum intensity before cells positive for the redistribution
were counted.
CellROX Green Assay
SHSY5Y cells were incubated with 5 µM CellROX Green
Reagent for 1 h at 37 C and 5% CO2 (Life Technologies,
United Kingdom). The cells were resuspended in PBS and
analyzed on a FACS using the 488 nm excitation laser (BD Accuri
C6, BD Biosciences). A total of 10,000 events were collected per
sample and resulting FL1 data were plotted on a histogram.
Nascent RNA and Protein Synthesis
Nascent RNA and protein synthesis were visualized, respectively,
using Click-iT RNA Alexa Fluor 488 Imaging Kit (Life
Technologies) and Click-iT HPG Alexa Fluor 488 Protein
Synthesis Assay Kit (Life Technologies) following the
manufacturer’s instructions and images were taken using a
100⇥ oil objective of LSM510 Meta confocal microscope
mounted on Axiovert200M using pinhole size of 1 AU.
RNA Extraction and Complementary
DNA (cDNA) Synthesis
Total RNA was extracted using TRIzol Plus RNA Purification
Kit (Life Technologies, United Kingdom). SHSY5Y were lysed
directly with 1 mL TRIzol reagent for 5 min at RT. The lysates
were resuspended and transferred to separate 1.5 mL tubes,
mixed with 200 µL chloroform, agitated by hand vigorously
for 15 s, and incubated for 2–3 min at RT. The samples were
spun at 12000 ⇥ g for 15 min at 4 C and the upper aqueous
phase which contains the RNA was collected. About 450 µL
of the top aqueous phase from each sample was transferred
to new RNase-free tubes and mixed vigorously with an equal
volume of 70% ethanol to obtain 35% ethanol in the mixture
and these were transferred to separate spin cartridges (with a
collection tube), spun at 12,000 ⇥ g for 15 s at RT and the
flow through was discarded. The cartridges were washed with
bu er I, spun at 12,000 ⇥ g for 15 s at RT and further washed
twice with bu er II at 12,000 ⇥ g for 15 s at RT. The cartridges
containing the RNA were dried by additional spin at 12,000 ⇥ g
for 1 min at RT. Using recovery tubes, the RNA from the di erent
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 August 2018 | Volume 12 | Article 220
fncel-12-00220 August 3, 2018 Time: 13:43 # 4
Maina et al. The Effect of Ab Oligomers on Nuclear Tau
cartridges was eluted after a 5 min incubation in 30 µL RNase-
free water and spun for 2 min at 16000 ⇥ g. The RNA extracts
were stored on ice and used for cDNA synthesis. The total
RNA extracted was used for cDNA synthesis using the High
Capacity cDNA Reverse Transcription Kit (Life Technologies,
United Kingdom). A 20 µL cDNA reaction was prepared for
each sample on ice, in PCR tubes, containing 10 µL total RNA
and 10 µL 2⇥ Reverse Transcription master mix supplemented
with RiboLock RNase Inhibitor at a concentration of 1 U/µL of a
reaction mixture (Life Technologies). All tubes were briefly spun
to eliminate bubbles and loaded to the thermal cycler (Biometra),
programmed to run at 25 C for 10 min, 37 C for 120 min
and 85 C for 5 min. The cDNA was collected and used for
qPCR.
Quantitative Polymerase Chain Reaction
(qPCR)
The synthesized cDNA from all samples were subjected to
qPCR using Maxima Probe/ROX qPCR Master Mix (2⇥) Kit
(Life Technologies) and Taqman gene expression assays (Life
Technologies, United Kingdom, Supplementary Table 2). A 1⇥
master mix su cient for a 25 µL-reaction for all samples in
duplicates was prepared from the Maxima Probe/ROX qPCR
Master Mix (2⇥), 20⇥ TaqMan gene expression assay and
Nuclease-free water, and 20 µL of the mixture were transferred
to required wells of a white 96-well semi-skirted PCR plate
for Roche Lightcycler (StarLab, United Kingdom). A cDNA
serial dilution of 1:1, 1:10, 1:100, and 1:1000 was prepared for
standard curve measurement and 5 µL of cDNA samples were
transferred to corresponding wells of the 96-well PCR plate.
A fresh master mix and standard curve were prepared for each
assay and template negative controls containing only nuclease
free H2O were included in every amplification. Absolute qPCR
was carried out on all samples using Roche LightCycler 480 II
(Roche Diagnostics, Basel, Switzerland). The cycling conditions
used were an initial run at 50 C for 2 min, initial denaturation at
95 C for 10 min, and 50 cycles of denaturation at 95 C for 15 s
and annealing and extension at 60 C for 1min and finally cooling
at 4 C. After the qPCR, transcript levels were automatically
determined using the standard curve method by the Roche
LightCycler 480 service software. Samples were normalized to
TBP and ACTB.
Statistical Analysis
All data were subsequently subjected to Kolmogorov–Smirnov
(K-S) normality test and then unpaired student’s t-test using
GraphPad InStat.
RESULTS
Ab42 Induces Oxidative Stress and Alters
Tau Phosphorylation and Localization
Without Cell Viability Loss or DNA
Damage
To investigate the e ect of oligomeric Ab on human tau
distribution, a human neuroblastoma cell line, SHSY5Y, was
selected as it produces normal endogenous levels of human
tau. This contrasts with mouse or rat tau produced in primary
neurons from laboratory animals, or with over-expression of
human tau from transgenic animal cells and provides a model
cellular system with which to explore human tau at normal
levels. The cells were di erentiated to increase their neuronal
characteristics (henceforth called D.SHSY5Y) and treated with
freshly prepared Ab42 oligomers (10 µM). Viability of the
di erentiated cells was una ected after 24 h incubation with
oligomeric Ab42 oligomers (Figure 1A). This is in contrast to
previous studies that show that undi erentiated SHSY5Y cell
viability is reduced by Ab42 oligomers (Soura et al., 2012).
To investigate whether more subtle dysfunctional e ects were
induced in di erentiated cells, we examined whether the Ab
causes DNA damage using a well-known DNA damage marker,
gH2Ax foci (Podhorecka et al., 2010). The Ab-treated D.SHSY5Y
showed no significant increase in numbers of gH2Ax foci
(Figure 1B). Ab has been suggested to lead to oxidative stress
(Butterfield et al., 2013) so we explored this in our cellular system
using the CellROX Green flow cytometry assay. This revealed
a significant increase in oxidative stress (13% increase) in the
D.SHS5Y5 cells (Figure 1C), suggesting that Ab42 can cause
oxidative stress, without exerting significant cell viability loss or
FIGURE 1 | Ab42 oligomers induce oxidative stress, without DNA damage or loss of cell viability 24 h post-incubation. (A) CellTiter Blue experiment showed that the
Ab incubation had no effect on cell viability. (B) Quantification of g-H2Ax-positive cells showed the absence of DNA damage following the Ab incubation. (C) Flow
Cytometry Experiment with CellROX Green showed that the Ab induces a significant level of oxidative stress. N = 5. ⇤P < 0.05.
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DNA damage on these di erentiated cells over the incubation
period of 24 h.
Ab toxicity is widely believed to have an impact on tau
protein, and several studies suggest that tau modifications, such
as phosphorylation/dephosphorylation, may be a signature of
general cellular stress (Egaña et al., 2003; Galas et al., 2006;
Kátai et al., 2016). It has previously been shown that the
di erentiation protocol used increases tau phosphorylation in
SHSY5Y cells, making the model ideal for the investigation
of AD-like changes (Jamsa et al., 2004). Western blotting was
used to investigate whether the Ab treatment impacts on tau
phosphorylation in D.SHSY5Y cells (whole cells). The levels
of two major tau species were measured and these were
compared to levels of total tau (henceforth referred to as
T-Tau): (1) Tau phosphorylated on Thr231 is one of the key
sites phosphorylated in AD, occurring before structural changes
to the tau molecule (Luna-Munoz et al., 2005) (henceforth
referred to as P-Tau) and; (2) Tau dephosphorylated on Ser 195,
198, 199, and 202 using Tau-1 antibody (henceforth referred
to as nP-tau). Cells incubated with oligomeric Ab42 show
a significant decrease in P-Tau and nP-Tau (Figure 2A and
Supplementary Figure S2). However, changes to whole cell T-tau
levels compared to cells treated with bu er alone were not
significant (Figure 2A). A decrease in nP-Tau indicates an
increase in phosphorylation at positions Ser 195, 198, 199, and
202. Considering the several epitopes on the tau molecule that
can be post-translationally modified, these changes suggest a
dynamic phosphorylation of di erent epitopes of tau following
Ab induced stress.
Incubation of D.SHSY5Y with Ab42 for 8 h (Noel et al.,
2016) or N2a cells with formaldehyde for 2–4 h (Lu et al.,
2013b), have been shown to result in the accumulation of
phosphorylated tau in the nucleus. Therefore, we focussed on
the e ect of Ab oligomer incubation for 24 h on the nuclear
tau species. For this, we employed immunofluorescence imaging
by the collection of Z Stacks to enable direct visualization
of the nuclear localized tau with DRAQ5 co-fluorescence and
allow unbiased quantification of the signals through the entire
nuclear volume (Figure 2B). Immunofluorescence suggested
no change in T-Tau following Ab42 incubation compared to
bu er treated control cells (Figure 2B) and comparison of
nuclear levels of T-Tau were not statistically significantly di erent
(Figure 2B). Bu er-treated D.SHSY5Y showed immunolabeling
of P-Tau in the nucleus (Figure 2B) and the level of P-tau
decreased significantly following Ab42 incubation (Figure 2B),
consistent with theWestern blotting results showing reduction of
P-Tau in the whole cell following Ab42 incubation (Figure 2A).
Importantly, merged images labeled for T-Tau and P-Tau
reveal an amount of T-Tau that is not detected by the P-tau
antibody, so we explored whether this represented nP-Tau.
Depending on the immunofluorescence detection protocol used
(Lu et al., 2014), nP-Tau appears as small, discrete, punctate
fluorescence within the nucleus in contrast to T-Tau and P-Tau
which show more di use staining (Figure 2C). Nuclear levels
of nP-Tau in Ab42 and bu er treated cells were quantified
and compared and revealed no significant change following
Ab42 incubation (Figure 2C), though there was a small but
significant decrease in nP-Tau levels in the total cell extract
revealed by Western blotting (Figure 2A). Fibrillarin (FBL) is a
marker for nucleoli and nuclear nP-Tau shows distinct punctate
labeling that co-localizes with the nucleolar protein, FBL in
untreated cells (Figure 3A). To investigate the impact of Ab
incubation on this nucleolar nP-Tau, we used FBL fluorescence
to segment the nucleolus, then quantified the abundance of
nP-Tau fluorescence following Ab incubation. This showed a
significant reduction in the nucleolar-nP-Tau (Figures 3B,C).
Since we found no di erence in the total nuclear levels of
nP-Tau (Figure 2Ci), the decrease in the nucleolar-specific
nP-Tau suggests changes in its nuclear/nucleolar ratio, which
has also been reported for other nucleolar proteins like FBL
(Kodiha et al., 2011). Overall, these results showed that the
Ab incubation leads to a reduction in total cell P-Tau and nP-
Tau levels and specifically decreases the levels of nucleolar nP-
Tau. Close inspection of the distribution of nucleolar marker
FBL in Ab42 treated cells reveals the expected puncta but
also very small speckles which may signal some nucleolar
distress.
Ab42 Induces Nucleolar Stress and
Reduces RNA and Protein Synthesis
Levels
Cellular stress is known to disrupt the integrity of the nucleolus
(Boulon et al., 2010). Therefore, the decrease in nucleolar
nP-Tau prompted us to investigate whether the nucleolus
was under stress. Stress can cause the nucleolus to undergo
reorganization associated with the degradation and redistribution
of nucleolar proteins. To investigate the presence of nucleolar
stress, we quantified the levels of UBF, TIP5 and FBL using
western blotting of the whole cell extract. UBF is a nucleolar
transcription factor that drives the transcription of rDNA
(Sanij et al., 2008; Bártová et al., 2010). TIP5 is a member of
the nucleolar remodelling complex (NoRC) that mediates the
silencing of a fraction of rDNA, leading to heterochromatin
formation and transcriptional silencing (Santoro et al., 2002).
Ab42 incubation led to a significant decrease in the levels of
UBF and TIP5 but no changes in FBL levels (Figure 4A). To
examine whether these changes occur specifically at the protein
production or transcript level, we quantified their respective
gene expression levels using qPCR. Ab42 incubation resulted
in a significant decrease in the gene expression levels of FBL,
UBF, and TIP5 (Figure 4B). This may indicate a reduction in
transcription as a likely contributor to the reduction observed
at the protein level. The absence of a di erence in the protein
level of FBL (Figure 4A), despite the decrease in its transcript,
may be due to a longer half-life of the protein (Vogel and
Marcotte, 2012). To further confirm the presence of nucleolar
stress, we examined whether the Ab42 incubation a ects rDNA
transcription and processing. The reduction in transcription
or maturation of 28S and 18S rRNA or increase in their
degradation has been suggested to contribute to nucleolar
dysfunction in AD (da Silva et al., 2000). qPCR analysis
showed that the Ab led to a significant reduction of 45S pre-
rRNA and levels of 18S and 28S rRNA (Figure 4C). Thus,
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FIGURE 2 | Ab42 oligomers change the phosphorylation of tau epitopes. (A) Western blotting on whole cell extracts showing the levels of Tau Thr231 (P-Tau), Tau-1
(nP-Tau) and total tau (T-Tau) following Ab administration. Normalized to b-actin. Immunofluorescence labeling indicating the presence of nuclear phosphorylated tau
(Bi), which significantly decreases following the Ab treatment, without changes in total nuclear tau (Bii) or nuclear nP-Tau (C). N = 5. ⇤P < 0.05.
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FIGURE 3 | Ab42 oligomers alter nucleolar tau localization 24 h post-incubation. Immunofluorescence labeling in buffer-treated cells show co-localization between
nP-Tau and FBL (A). 10 µM Ab42 treatment induces the delocalization of nP-Tau from FBL (B). Quantification showed that this altered colocalization is associated
with a significant reduction in the nucleolar nP-Tau (C) N = 5. ⇤P < 0.05.
these findings rea rm that Ab incubation results in nucleolar
stress with an associated reduction of rRNA production and
processing.
Given the changes observed in the levels of 45S-pre-rRNA
and gene expression levels of other nucleolar proteins, global
RNA synthesis levels were examined using the Click-iT RNA
Imaging assay. Incubation of D.SHS5Y5 cells with oligomeric
Ab42 showed a significant reduction in nascent RNA synthesis
(Figure 4D). To explore whether these changes may be due
to changes in heterochromatin levels, H3K9me3 was used as
a constitutive heterochromatin marker. H3K9me3 is known
for its role in transcriptional repression, and it accumulates
to form foci at constitutive heterochromatin (Saksouk et al.,
2015). A significant increase was observed in the nuclear
level of H3K9me3 and its foci in D.SHSY5Y cells incubated
with Ab42 (Figure 4E). This finding compliments the qPCR
and Click-iT RNA labeling data, which reveal a decline
in RNA levels (Figures 4B,D). Since we observed a global
increase in heterochromatin, a decrease in RNA synthesis and
rDNA transcription, we explored whether this culminates in a
reduction in synthesized proteins. Using Click-iT HPG Protein
Synthesis Assay, we observed that incubation of cells with
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FIGURE 4 | Ab42 induces nucleolar stress and inhibit RNA and Protein Synthesis 24 h post-incubation. (A) Western blotting revealed that Ab treatment led to a
significant decrease in UBF, TIP5, but not FBL. Normalized to b-actin. (B) qPCR analysis showed a significant reduction of UBF, TIP5, and FBL transcripts.
Normalized to b-actin or TBP. (C) qPCR analysis of rDNA transcription and processing showed that the Ab incubation resulted in a significant decrease in 45S
pre-rRNA synthesis and processing of 18S rRNA and 28S rRNA. Normalized to b-actin or TBP. (D) Quantitative Click-iT RNA immunofluorescence labeling showed
that the Ab causes a global reduction in newly synthesized RNA, (E) which is associated with a nuclear increase in H3K9me3 intensity and foci. (F) Quantitative
Click-iT HPG Alexa Fluor 488 immunofluorescence labeling showed a significant decrease in nascent protein synthesis following the Ab treatment. (G) Quantitative
immunofluorescence labeling for phosphor S51 eukaryotic translation initiation factor 2A (EIF2A-P) showed no changes following the Ab treatment. For A, N = 5,
B–E, N = 4 and F,G, N = 3, ⇤P < 0.05 (See also Supplementary Figure 1).
Ab led to a significant decrease in the global levels of newly
manufactured proteins (Figure 4F). Phosphorylation of elFa
plays an important role in regulation of protein synthesis
during homeostatic control and stress (Holcik and Sonenberg,
2005). An increased level of eIF2a phosphorylation has been
associated with the pathogenesis of AD (Hoozemans et al.,
2009), as well as other neurodegenerative diseases (Halliday
and Mallucci, 2015). Therefore, we next investigated whether
Ab incubation also a ects the eIF2a pathway. However, using
quantitative eIF2a immunofluorescence and western blotting,
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FIGURE 5 | Early responses to Ab42 exposure are oxidative stress and subtle nucleolar stress. (A) Flow Cytometry Experiment with CellROX Green showed that Ab
incubation for 2 h induces a significant level of oxidative stress. (B) Western blotting revealed that at the 2 h time point, Ab causes a reduction of only UBF, not FBL
or TIP5. Normalized to b-actin. Quantitative Click-iT RNA immunofluorescence labeling showed no change in newly synthesised RNA (C); H3K9me3 (D); or in newly
synthesized proteins (E). N = 5, ⇤P < 0.05 (See also Supplementary Figure 4).
no di erence in eIF2a phosphorylation between control and
Ab-treated cells was observed (Figure 4G and Supplementary
Figure 1B).
First Responses to Ab42 Exposure Are
Oxidative Stress and Subtle Nucleolar
Stress
Ab induces oxidative stress and a reduction in the levels of
protein synthesis without causing significant DNA damage or
a ecting cell viability. To identify the earliest event induced
by the Ab incubation, we studied the changes that result
from a short exposure to Ab42 (Figure 5). D.SHSY5Y cells
treated with Ab42 oligomers for 2 h showed no impact on tau
modifications and did not result in loss of cell viability or DNA
damage (data not shown). However, Ab42 incubation resulted
in a significant increase in oxidative stress as measured using
CellROX (Figure 5A), slightly lower than after 24 h incubation
(Figure 1C). To examine whether this results in nucleolar stress,
levels of FBL, UBF, and TIP5 were measured using western
blotting of the whole cell fraction. Notably, while FBL and TIP5
remain unchanged, the short exposure to Ab led to a modest,
but significant reduction in UBF (Figure 5B and Supplementary
Figure S3). Considering the critical role of UBF in rDNA
transcription, this decrease may lead to a reduction of rDNA
transcription in response to cellular stress (Boulon et al., 2010).
However, the short Ab exposure did not a ect the levels of global
RNA synthesis, H3K9me3 or protein synthesis (Figures 5C–E).
Hence, the findings from the exposure to Ab for 2 and
24 h reveal that early consequences of Ab incubation in the
D.SHSY5Y are oxidative stress and subtle nucleolar stress. These
become exacerbated over time, into a robust nucleolar stress with
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nucleolar tau redistribution that negatively impacts on the levels
of RNA and protein synthesis within the cells.
DISCUSSION
In AD, changes in Ab42 and tau levels appear decades before the
onset of dementia (Jack et al., 2013). Several studies have revealed
that alteration in the protein synthesis machinery, from the
nucleolus to the ribosomes, occurs in the early stage of the disease
(Ding et al., 2005; Hernandez-Ortega et al., 2015). Ab is thought
to cause subtle changes in neuronal function that gradually leads
to cell death, whilst tau plays a very significant role in the
process of neuronal dysfunction. Here, we investigated the early
e ects of oligomeric Ab42 on the protein synthesis machinery
implicated in the disease and examine the influence of Ab42
on di erent species of nuclear tau and their distribution using
di erentiated human neuroblastoma cell line which expresses
normal levels of human tau. Consistent with previous findings
from human cortical slices treated with Ab oligomers for 24 h
(Sebollela et al., 2012), we found that the incubation of D.SHSY5Y
with freshly prepared 10 µM Ab42 oligomers for 24 h did not
a ect their viability or result in DNA damage. Previous studies
have shown that Ab42 treatment increases the level of reactive
oxygen species (ROS) in primary neurons (De Felice et al.,
2007). Here we revealed that Ab42 induced oxidative stress,
without exerting significant cell viability loss or DNA damage
on these di erentiated cells. Indeed, several lines of evidence
have indicated that Ab42 can induce oxidative stress, which is
thought to play a critical role in AD progression (Butterfield et al.,
2013).
Ab toxicity is widely believed to aberrantly impact on tau
protein, and several studies suggest that tau modifications, such
as phosphorylation/dephosphorylation, may be a signature of
general cellular stress (Egaña et al., 2003; Galas et al., 2006; Kátai
et al., 2016). Here we reveal that Ab42 incubation results in
decreased levels of both nP-Tau and P-Tau, implying a relative
increase in tau phosphorylated on Ser 195, 198, 199, and 202
and a decrease in tau Thr231 phosphorylation. Consistent with
this, it has previously been shown that incubation of primary
neurons with Ab42, for up to 8 h, leads to a Pin1-mediated
dephosphorylation of tau on Thr231, Ser199, Ser396, Ser400,
and Ser404, with a progressive increase in its phosphorylation
on Ser262 (Bulbarelli et al., 2009). This has been suggested
to serve as an early response to prevent Ab-induced tau
hyperphosphorylation (Bulbarelli et al., 2009), which can be
influenced critically by its phosphorylation at Thr231 (Lin et al.,
2007). Furthermore, a recent study revealed that Ab induces the
phosphorylation of tau on Threonine 205 as an early mechanism
for neuroprotection against excitotoxicity (Ittner et al., 2016).
Thus, it seems that di erent stress signals or kinases could
change the cellular activity and behavior of the tau molecule
(Pooler et al., 2012; Lu et al., 2013b). Although recent studies
have begun to shed light on how cellular stress impacts on
nuclear tau (Sultan et al., 2011; Lu et al., 2013a,b; Noel et al.,
2016; Maina et al., 2018), how this is a ected in AD is not
clear. Interestingly, it was recently shown that nuclear tau
decreases in both the CA1 and dentate gyrus regions of the
AD brain with disease progression (Hernandez-Ortega et al.,
2015).
Cellular stress induces the cytoplasmic and nucleoplasmic
distribution of nucleolar proteins (Kodiha et al., 2011). Here
we revealed that Ab42 incubation resulted in a reduction in
nucleolar nP-Tau levels colocalizing with the nucleolar marker
FBL. Furthermore, we observed a decrease in the levels of TIP5
and UBF as well as a decrease in rDNA transcription pointing to
an increased level of nucleolar stress following Ab42 treatment.
Interestingly, oxidative and nucleolar stress appear to be earliest
changes due to the Ab toxicity, indicating the importance of
the maintenance of cellular redox homeostasis and nucleolar
integrity for cellular health. Human postmortem studies on the
AD brain revealed that the nucleolus becomes a ected in the
early stage of the disease, which progresses with disease severity.
UBF was shown to specifically reduce in both the CA1 and
dentate gyrus from Braak stage 1 to 6 (Hernandez-Ortega et al.,
2015). A similar altered level of nucleolar protein was also found
in the Parkinson’s disease brain (Garcia-Esparcia et al., 2015).
Collectively, our findings point to a potential early mechanism
of Ab toxicity, resulting in oxidative and nucleolar stress in the
absence of cell death, and alteration in the phosphorylation level
of tau epitopes, resulting in a change in tau’s localization within
the nucleolus.
To investigate whether these changes a ect the rRNA and
protein levels, we explored the e ect of Ab on the protein
translation machinery since rRNA are required for the assembly
of functional ribosomes. A significant reduction in 45S-pre-
rRNA, 18S, and 28S rRNA, and a subsequent decrease in
global RNA synthesis indicates a global rearrangement of
chromatin configuration, which may indicate a decrease in
transcription. Indeed, this was associated with an increase in the
heterochromatin marker, H3K9me3. AD-associated reduction
in RNA and increase in heterochromatin formation has been
reported in cortical neurons (Crapper et al., 1979; Mann et al.,
1980; McLachlan et al., 1991). Consistent with this, microarray
analysis of human cortical neurons challenged with Ab oligomers
previously showed that they result in ⇠70% down-regulation of
gene expression of 345 genes (Sebollela et al., 2012). Synthesized
RNAs are translated into proteins through the recruitment and
assembly of many factors, such as ribosomes. Depending on the
metabolic activity of cells, rDNA transcription in mammalian
cells accounts for ⇠35 to 65% of total cellular transcription
(Strohner et al., 2004). This reduction in protein synthesis could
be due to a collective low availability of RNA and rRNA.
It has been observed that during stress, protein synthesis can
also be inhibited through Serine 51 phosphorylation of a subunit
of eukaryotic initiation factor 2 (eIF2a) (Holcik and Sonenberg,
2005). This is thought to enable the reduction of cellular energy
expenditure and the production of unwanted proteins that could
interfere with the stress response. In our model of Ab-induced
pathogenesis, nucleolar stress associated with a deficit in rDNA
transcription appear to occur earlier than eIF2a phosphorylation.
The deficits in protein synthesis observed in patients with MCI
and early AD could be due to deficiencies in rRNA abundance,
rather than eIF2a phosphorylation, since the reduction in rRNA,
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would translate to a decrease in the abundance of ribosomes
and thus drop in protein translation. In our model, this links
Ab to the early changes in protein synthesis machinery in
AD (Ding et al., 2005, 2006; Hernandez-Ortega et al., 2015).
Consistent with early studies on chromatin and RNA changes
in AD (Mann et al., 1980; McLachlan et al., 1991) and recent
findings with Ab (Sebollela et al., 2012), our results also indicate
that the increased heterochromatin formation and reduction in
the transcripts could contribute to the decrease in synthesized
proteins due to the presence of Ab oligomers. Although recent
evidence on gene expression in AD shows variability between
brain regions and proteins, AD pathology has been associated
with di erential changes in gene expression, where some
pathways show decreased gene expression, while others show
an increase (Liang et al., 2008a; Sebollela et al., 2012). Data
from laser-capture micro-dissected neurons previously showed
that some of the regions a ected early in AD show under-
expression of genes involved in energy metabolism (Liang et al.,
2008b). Therefore, the decrease in RNA transcripts observed
here reiterates the importance of Ab in the early process of the
disease.
CONCLUSION
The amyloid cascade hypothesis places Ab as the primary culprit
for the pathogenesis of AD (Hardy and Higgins, 1992). Our
findings here are consistent with the previous investigation
showing a suppressive e ect of Ab42 on the cholinergic system,
and gene expression (Sebollela et al., 2012), and supports a role
for Ab in influencing ribosome and protein synthesis deficits
observed in this disease (Ding et al., 2005, 2006; Hernandez-
Ortega et al., 2015). The changes are observed in the absence
of overt toxicity (e.g., loss of cell viability) and correlate well
with deficits in protein synthesis machinery that have been
observed in MCI, a time-point in the progression of AD
when there is no evidence of significant neuronal loss (Ding
et al., 2005, 2006). Here we directly link Ab in altered protein
synthesis machinery to early cellular changes that impact on
the progression of the disease, decades before full-blown AD
(Jack et al., 2013). The results suggest that Ab may play a
role in driving deficits in the component of the translation
machinery, from the nucleolus to the ribosomes, that occurs
with AD progression (Hernandez-Ortega et al., 2015), perhaps
an influence on nuclear tau which is essential for chromatin
stability (Mansuroglu et al., 2016). These findings implicate Ab
as a culprit for the heterochromatinization and decrease in RNA
levels that are reported to occur during the progression of this
disease (Crapper et al., 1979; Mann et al., 1980; McLachlan et al.,
1991).
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